Cantor Fitzgerald Initiates Coverage On ProMIS Neurosciences with Overweight Rating

Cantor Fitzgerald analyst Pete Stavropoulos initiates coverage on ProMIS Neurosciences (NASDAQ:PMN) with a Overweight rating.